New drug combo trial seeks to control advanced cancers
NCT ID NCT07169994
Summary
This study is testing a new drug called YL202, given alongside other cancer treatments, to see if it is safe and effective for people with advanced solid tumors like breast or lung cancer. The main goals are to find the safest dose and see if the treatment helps shrink tumors. It is for adults whose cancer has progressed despite standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital Of Hebei University
NOT_YET_RECRUITINGBaoding, Hebei, 71051, China
Contact
-
Affiliated Zhongshan Hospital Dalian University
NOT_YET_RECRUITINGDalian, Liaoning, 116001, China
Contact
-
Affiliated Zhongshan Hospital Dalian University
NOT_YET_RECRUITINGJinan, Shandong, 250117, China
Contact
-
Anhui Provincial Hospital(The First Affiliated Hospital of Ustc)
NOT_YET_RECRUITINGHefei, Anhui, 230001, China
Contact
-
Anyang Cancer Hospital
NOT_YET_RECRUITINGAnyang, Henan, 455100, China
Contact
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 201321, China
Contact
-
Fujian Cancer Hospital
NOT_YET_RECRUITINGFuzhou, Fujian, 350014, China
Contact
-
Ghang xi Medical University Cancer Hospital
NOT_YET_RECRUITINGNanning, Guangxi, 530028, China
Contact
-
Harbin Medical University Cancer Hospital
NOT_YET_RECRUITINGHarbin, Heilongjiang, 150081, China
Contact
-
Jiangsu Province Hospital（The First Affiliated Hospital With Nanjing Medical University, Jiangsu Women And Children Health Hospital)
NOT_YET_RECRUITINGNanjing, Jiangsu, 210029, China
Contact
-
Jiangxi Cancer Hospital
NOT_YET_RECRUITINGNanchang, Jiangxi, China
Contact
-
Liaoning cancer hospital &institute
NOT_YET_RECRUITINGShenyang, Liaoning, 110042, China
Contact
-
Meizhou People's Hospital（Huangtang Hospital）Meizhou Academy of Medical Sciences
NOT_YET_RECRUITINGMeizhou, Guangdong, 514031, China
Contact
-
Shanxi Cancer Hospital
NOT_YET_RECRUITINGTaiyuan, Shanxi, 30013, China
Contact
-
Sichuan Academy of Medical Sciences&Sichuan Provincial People's Hospital
NOT_YET_RECRUITINGSichuan, Sichuan, 610072, China
Contact
-
Sun Yat-sen University Cancer Center
NOT_YET_RECRUITINGGuangzhou, Guangdong, 510555, China
Contact
-
The First Affiliated Hospital of Henan University of Science and Technology
NOT_YET_RECRUITINGLuoyang, Henan, 471023, China
Contact
-
The First People's Hospital of Changde City
NOT_YET_RECRUITINGChangde, Hunan, 415000, China
Contact
-
Tianjin Cancer Hospital Airport Hospital
NOT_YET_RECRUITINGTianjin, Tianjin Municipality, 300300, China
Contact
-
Xiangyang Central Hospital
NOT_YET_RECRUITINGXiangyang, Hubei, 441138, China
Contact
Conditions
Explore the condition pages connected to this study.